(800) 477-0055
left arrow right arrow
font size
-
+

EVO ICL™

Choosing the right vision correction procedure depends on a person’s unique vision needs, eye health, and many other conditions. If you have always wanted LASIK but have been told you’re not a candidate because you are too nearsighted or your corneas are too thin, the EVO ICL™ may be your answer!

View Video

EVO ICL is an Implantable Collamer Lens (ICL) designed to correct nearsightedness with and without astigmatism. The small flexible lens is placed behind the iris (the colored part of the eye) and in front of the natural crystalline lens in order to improve vision. It’s like having your doctor implant a lens similar to a contact lens into your eye so you can live without the daily hassles and maintenance of typical contact lenses.

Visian ICL Procedure Diagram

 Visian ICL In the Eye

EVO ICL is well-suited for a wide variety of people. Ideal candidates for EVO ICL are aged 21 to 45 with nearsightedness, with or without astigmatism, and have maintained a stable prescription for at least one year. Other conditions may also be a factor so a thorough pre-surgical evaluation from one of our doctors is necessary to ensure your eligibility. If you are seeking a solution to decrease or eliminate the cost and frustration of traditional contacts or glasses, EVO may be your answer. Contact us to discuss if EVO ICL is right for you.

What to Expect During Your EVO ICL Procedure

EVO ICL lens is made of biocompatible Collamer material that works in harmony with your eye. Your eye doctor will create a small opening in your cornea that will be used to insert and position the EVO ICL. For most patients, the procedure is virtually painless with numbing eye drops and it typically takes less than 20-30 minutes. Patients typically experience improved vision right away and a quick recovery time.

Benefits of EVO ICL

  • Provides clear, sharp vision 1,2
  • 20 to 30-minute procedure
  • Quick recovery time
  • Removable by your doctor
  • Offers UV protection
  • Not visible once in place
  • Can treat nearsightedness with or without astigmatism
  • For patients who may not be candidates for LASIK or other vision correction procedures due to thin corneas 3,4
  • Does not cause dry eye syndrome 5
  • Excellent vision both day and night 6,7
  • Over 2 million ICLs distributed worldwide
  • 99.4% of patients surveyed would have the EVO Lens procedure again 8

Cost and Financing for EVO ICL

The cost of an EVO ICL procedure can vary depending on your personalized treatment plan. Many EVO ICL patients look forward to spending less in the long run with the EVO ICL compared to the continued costs of contacts and glasses. Ask about financing options and payment plans that may be available for your EVO ICL procedure.

Contact Us Today!

Our doctors have performed thousands of lens implantation procedures and continue to be some of the most experienced and skilled surgeons in the area. So, if you have been waiting for the answer to your vision problems, don’t wait any longer. The EVO ICL™ is here! Contact our Vision Correction team today to schedule your complimentary evaluation.


Important Safety Information

The EVO Visian ICL lens is intended to correct/reduce nearsightedness between -3.0 D up to -20.0 D and treat astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before. Since implantation of the EVO Visian ICL is a surgical procedure, before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts. You should NOT have EVO Visian ICL surgery if your doctor determines that 1) the shape of your eye is not appropriate, 2) you do not meet the minimum endothelial cell density for your age at the time of implantation, 3) you have moderate to severe glaucoma, 4) your vision is not stable; or 5) if you are pregnant or nursing.

For additional information with potential benefits, risks and complications please visit DiscoverICL.com


1. Sanders D, Vukich J. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006

2. Igarashi A, Kamiya K, Shimizu K, Komatsu M. Visual Performance after implantable Collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Opthalmol. 2009

3. Parkhurst G, Psolka M, Kezirian G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481

4. Gimbel H, et al. Management of myopic astigmatism with phakic intraocular lens implantation. Journal of Cataract & Refractive Surgery, Volume 28, Issue 5, 883 – 886.

5. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263.

6. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016 Jun 29;10:1209-15.

7. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263.

8. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clinical Ophthalmology 2018: 12: 2427–2438